Business
EU approval for active substances
EU approval for active substances.
About this update from Eden Research Plc
[{"type":"text","content":"\n \nRNS Number : 0500F Eden Research plc 20 May 2013 \n \n\nEden Research plc\n(\"Eden\" or \"Company\")\n \nKey milestone achieved with EU approval for active substances\n \nApproval paves the way for final product approvals and sales\n \n \nEden Research plc (AIM: EDEN), the AIM listed agrochemical and encapsulation development company, announces that the three active substances (\"actives\") that are used in the Company's lead product, 3AEY, have been approved for use in plant protection products by the European Commission (\"EC\") under Regulation (EC) No. 1107/2009 within the European Union (\"EU\").\n \nThese approvals are the successful outcome of a process which has taken over seven years to complete and into which the Company has invested considerable time and resources. This is the key regulatory milestone for the business and allows the actives to be used with Eden's encapsulation technology in any combination to create a range of agrochemical products for a variety of applications. These approvals will also trigger decisions by other regulators outside of the EU, particularly in Africa, who monitor European regulatory approvals and where sales are expected in a much shorter timeframe.\n \nIn Europe, individual products, such 3AEY, require separate national approvals. The Company's lead agrochemical product, 3AEY, isa very effective and naturally derived Botryticide. Botrytis is a widespread fungal disease that causes grey mould on most fruits and vegetables often leading to the rapid loss of commercially viable crops. The average losses from affected crops account for around 20% of the total harvest, costing in the region of 10-100 billion euros worldwide. The market size for Botryticides is around $300m per annum.\n \nClive Newitt, Managing Director of Eden comments: \"The regulatory process that exists for new actives in plant protection products is becoming increasingly onerous and so to receive approval for three new actives is a great achievement. \n \n\"The inherent value of owning the registration for three actives is significant. It enables Eden to commercialise products in Europe and helps in the rest of the world as regulators in other continents, such as Africa, closely monitor what happens in Europe where the regulatory framework is highly regarded.\n \n...